-
-
-
-
-
-
News
-
-
Contact UsThe company focuses on the research, development, production, and sales of chemical raw materials and their formulations. All products have passed national GMP certification, and core products have successively passed official pharmaceutical regulatory certifications from multiple countries, including the EU EDQM, US FDA, Japanese PMDA, and South Korean MFDS. Following its successful listing on the Shenzhen Stock Exchange's ChiNext board on April 4, 2023, Keyuan Pharmaceutical has entered a phase of rapid development driven by both digital intelligence and capital, with its business spanning dozens of countries and regions worldwide.
Inspire ideas, clarify the roadmap, boost morale, and embark on a new journey! Keyuan Pharmaceutical Holds Its 2024 Year-End Performance Review Conference!
Publish Time:
2025-01-20
New year, new momentum; fresh spring, new initiatives. Kexuan Pharmaceutical will take this performance review meeting as an opportunity to align our vision even more closely around achieving our 2025 targets. We’ll intensify our focus on market expansion, procurement optimization, lean production, organizational development, and safety & environmental protection—all while staying profit-driven, leveraging R&D as our engine of growth and ensuring robust system support. Let’s transform our work style, strengthen our execution and learning capabilities, act decisively without delay or evasion, respond swiftly, and remain relentlessly committed until we reach our goals—no excuses, no compromises!
On January 19, Keyuan Pharmaceutical (stock code: 301281.SZ) held its grand 2024 Year-End Performance Review Meeting, where the company comprehensively summarized and reflected on the highlights and areas for improvement from the past year. The meeting also outlined clear strategies and development plans for 2025, inspiring all employees to continue advancing with determination and courage, boldly charging forward toward our goals for 2025. Over 50 representatives attended, including company executives, heads of various departments, and plant directors.
The meeting kicked off with everyone singing the Linuo Anthem and reciting the Linuo Ode together. At the very beginning, the company specially invited Ma Yubiao, Director of Human Resources at the Group’s Business School, to deliver a training session titled "Human Resource Management for Non-HR Professionals." The session focused on key areas such as role positioning, talent selection, talent utilization, and talent development. Through engaging case studies and practical management techniques, Ma provided clear and insightful guidance on how to seamlessly integrate HR management principles into daily work practices, ultimately fostering stronger team collaboration and supporting employees' personal growth.
At the meeting, heads of various departments and factory directors took to the stage one by one to deliver their reports. They discussed 2024's key tasks, achievements, innovative initiatives, as well as existing challenges, and outlined their plans for the upcoming period. The presentations provided a detailed account of Keway Pharmaceutical's remarkable accomplishments and valuable insights gained over the past year in areas such as technology R&D, business expansion, safe production, and marketing. Each report was packed with highlights, supported by concrete data and real-life examples, clearly demonstrating the team's unwavering dedication and diligent efforts throughout the year.
Over the past year, Keyuan Pharmaceutical has fully implemented the lean and digital management philosophy, with everyone—from top leadership to frontline employees—working together to set clear goals and pressing forward under pressure. As a result, the company achieved robust growth against industry trends and made precise improvements in key areas such as operational performance, quality control, and cost reduction while boosting efficiency. This year, Keyuan Pharmaceutical remained steadfast in upholding its unwavering commitment to quality, continuously building a market-oriented quality management system that aligns with international standards. The company organized numerous initiatives, including extensive quality training sessions and quality competitions, to significantly enhance every employee’s awareness of quality excellence. Meanwhile, Keyuan Pharmaceutical rigorously maintained its safety standards, strengthening safety management practices, refining safety protocols, and intensifying safety training programs. Thanks to these efforts, the company successfully met its ambitious safety objectives: achieving "zero safety incidents, zero environmental pollution, and zero administrative penalties" for the entire year.
The conference summarized the achievements of 2024 and set forth new expectations for the exciting journey ahead in 2025. Looking to the future, Keyuan Pharmaceutical will continue to ramp up R&D investments, enhance its innovation capabilities, and drive product improvements and upgrades—steadily elevating both product quality and market competitiveness. In terms of marketing, Keyuan Pharmaceutical will further broaden its global perspective, strengthen brand-building efforts, expand distribution channels, and strive to increase its market share. Meanwhile, on the team-building front, Keyuan Pharmaceutical will remain committed to nurturing and attracting top talent, assembling a highly skilled, professional, battle-ready, and victory-oriented "iron army" that will provide robust human resources support for the company’s long-term growth and success.
New year, new momentum; fresh beginnings, fresh actions. Kexuan Pharmaceutical will take this performance review meeting as an opportunity to align our vision even more closely around achieving our 2025 targets. We’ll intensify our focus on market expansion, procurement optimization, lean production, organizational development, and safety & environmental protection—driven by profitability, powered by R&D innovation, and underpinned by a robust system framework. Let’s transform our work style, strengthen our execution and learning capabilities, stay proactive rather than procrastinating or shying away from challenges. Together, we’ll respond swiftly and relentlessly pursue our goals—never backing down until we succeed!
Though the road may be long, persistence will lead to the destination; though the task may be challenging, determination will ensure its success! In 2025, all of Keway Pharmaceutical—employees at every level—will unite with unwavering focus and commitment to fully and resolutely achieve our targets!
Latest News
Address: No. 26, Keyuan Street, Shanghe County, Jinan City, Shandong Province
Free Service Hotline